Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism OGG1 activators(8-oxoguanine DNA glycosylase activators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC17H21N3 |
InChIKeyZQMGQZOHIDOPCQ-UHFFFAOYSA-N |
CAS Registry1002801-51-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | SE | 24 Jun 2022 | |
disorder of aging | Preclinical | SE | 24 Jun 2022 | |
Inflammation | Preclinical | SE | 24 Jun 2022 | |
Neoplasms | Preclinical | SE | 24 Jun 2022 |